Comparable stake leader
BAKER BROS. ADVISORS LP
SEC ownership of BeOne Medicines Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001651308.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
11 Jun 2026
- Public ticker
- ONC on Nasdaq, BEIGF on OTC
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BAKER BROS. ADVISORS LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BAKER BROS. ADVISORS LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001651308
- Issuer location
- Basel
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BeOne Medicines Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
11 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 8%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-8 of 50 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 8%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
8%
HHLR ADVISORS, LTD.
4.9%
Capital International Investors
4.2%
Titus B. Ball
0.01%
Corazon (corsee) D. Sanders
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
Julian C. Baker · Director · Company
|
8%
|
$36,692,201,272
115,912,814 shares
|
-$1,740,708 | 11 Jun 2026 |
| HHLR ADVISORS, LTD. |
3/4/5
13D/G
13F
10%+ Owner · Company
|
4.9%
from 13D/G
|
$25,009,148,200
125,045,741 shares
|
— | 02 Dec 2024 |
| Capital International Investors |
13F
13D/G
Company
|
4.2%
from 13D/G
|
$1,231,236,530
4,158,726 shares
|
— | 31 Mar 2026 |
| Titus B. Ball |
3/4/5
Principal Accounting Officer
|
0.01%
|
$29,591,575
99,645 shares
|
-$120,232 | 11 Jun 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0%
|
$16,175,955
54,470 shares
|
-$1,859,272 | 22 May 2026 |
| Elizabeth Fisher Mooney |
3/4/5
Director
|
0%
|
$5,636,490
18,980 shares
|
— | 11 Jun 2026 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
0.34%
|
$1,477,479,502
4,975,181 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13F
Company
|
0.25%
|
$1,096,891,494
3,693,610 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$271,728,454.
Buys
$0
Insiders: 0
Sells
$271,728,454
Insiders: 10
Net
-$271,728,454
Shares: -872,432
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 872,432
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 581,664 | $0 | $179,916,654 | -$179,916,654 |
| 3-6 | 0 | 2,333 | $0 | $785,944 | -$785,944 |
| 6-9 | 0 | 124,951 | $0 | $39,701,704 | -$39,701,704 |
| 9-12 | 0 | 163,484 | $0 | $51,324,152 | -$51,324,152 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 31 reporting-owner rows connected to BeOne Medicines Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
31
Largest Forms 3/4/5 holder
HHLR ADVISORS, LTD.
Net 12M change
-$271,728,455
Latest report
17 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 10%+ Owner | $25,009,148,200 | Filing P/S | 02 Dec 2024 | ||
| AMGEN INC | 10%+ Owner | $3,419,356,261 | Mixed | 10 Sep 2021 | ||
| BAKER BROS. ADVISORS LP | Director | $2,148,471,339 | Mixed | 11 Jun 2026 | ||
| John Oyler | Chief Executive Officer, Director | $1,581,047,920 | -$215,866,030 | -12% | Median | 17 Jul 2026 |
| Xiaodong Wang | Director, Chair, Scientific Advisory Brd | $1,390,574,794 | Mixed | 11 Jun 2026 | ||
| Lai Wang | President, Global Head of R&D | $677,973,303 | -$4,223,040 | -0.62% | Mixed | 23 Jun 2026 |
| Donald W. Glazer | Director | $564,671,459 | Mixed | 05 Jun 2024 | ||
| Xiaobin Wu | President and COO | $379,392,989 | -$35,994,933 | -8.7% | Mixed | 23 Jun 2026 |
| Howard Liang | CFO & Chief Strategy Officer | $322,615,606 | Mixed | 28 Jun 2021 | ||
| Aaron Rosenberg | Chief Financial Officer | $118,161,690 | -$508,296 | -0.43% | Mixed | 11 Jun 2026 |
| Chan Henry Lee | SVP, General Counsel | $96,573,332 | -$12,959,803 | -12% | Median | 08 Jul 2026 |
| Julia Aijun Wang | Chief Financial Officer | $88,611,076 | Mixed | 01 Jul 2024 | ||
| Felix Baker | Director | $47,975,799 | Mixed | 11 Jun 2026 | ||
| 667, L.P. | Director | $47,975,799 | Mixed | 11 Jun 2026 | ||
| Julian C. Baker | Director | $47,975,799 | Mixed | 11 Jun 2026 | ||
| Baker Bros. Advisors (GP) LLC | Director | $47,975,799 | Mixed | 11 Jun 2026 | ||
| Baker Brothers Life Sciences LP | Director | $47,975,799 | Mixed | 11 Jun 2026 | ||
| Jane Huang | CMO, Hematology | $33,246,160 | Mixed | 14 Dec 2021 | ||
| Titus B. Ball | Principal Accounting Officer | $29,591,575 | -$120,232 | -0.4% | Mixed | 11 Jun 2026 |
| Anthony C. Hooper | Director | $24,862,328 | Mixed | 11 Jun 2026 |
Recent insider transactions for BeOne Medicines Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $20,163,907 | $312.00 | -64,628 | 0 | 17 Jul 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Options Exercise | 64,628 | 64,628 | 17 Jul 2026 | Direct | |||
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -65.5% | -840,164 | 441,870 | 17 Jul 2026 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $52,992,224 | $318.09 | -166,597 | 0 | 16 Jul 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Options Exercise | 166,597 | 166,597 | 16 Jul 2026 | Direct | |||
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -100% | -2,165,761 | 0 | 16 Jul 2026 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $36,359,374 | $311.94 | -116,557 | 0 | 15 Jul 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Options Exercise | 116,557 | 116,557 | 15 Jul 2026 | Direct | |||
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -100% | -1,515,241 | 1 | 15 Jul 2026 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Options Exercise | 133,600 | 133,600 | 14 Jul 2026 | Direct | |||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $44,626,424 | $305.95 | -145,861 | 0 | 14 Jul 2026 | Direct |
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -100% | -1,736,800 | 0 | 14 Jul 2026 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $14,766,883 | $304.35 | -48,520 | 0 | 13 Jul 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Options Exercise | 48,520 | 48,520 | 13 Jul 2026 | Direct | |||
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -33.3% | -630,760 | 1,264,666 | 13 Jul 2026 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $3,489,925 | $298.34 | -11,698 | 0 | 10 Jul 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Options Exercise | 11,698 | 11,698 | 10 Jul 2026 | Direct | |||
| John Oyler | ONC | Share Option (Right to Buy) | Options Exercise | -7.43% | -152,074 | 1,895,426 | 10 Jul 2026 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $200,833 | $302.46 | -664 | 0 | 08 Jul 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 664 | 664 | 08 Jul 2026 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -33.4% | -8,632 | 17,238 | 08 Jul 2026 | Direct | ||
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -100% | $356,927 | $276.26 | -1,292 | 0 | 23 Jun 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $933,592 | $273.78 | -3,410 | 0 | 23 Jun 2026 | Direct |
| Lai Wang | ONC | American Depositary Shares | Sale | -100% | $295,553 | $276.74 | -1,068 | 0 | 23 Jun 2026 | Direct |
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -100% | $361,997 | $266.76 | -1,357 | 0 | 16 Jun 2026 | Direct |
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $980,686 | $265.55 | -3,693 | 0 | 16 Jun 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $156,925 | $265.98 | -590 | 0 | 16 Jun 2026 | Direct |
| Lai Wang | ONC | American Depositary Shares | Sale | -100% | $310,236 | $265.39 | -1,169 | 0 | 16 Jun 2026 | Direct |
| Titus B. Ball | ONC | American Depositary Shares | Sale | -100% | $43,467 | $257.20 | -169 | 0 | 11 Jun 2026 | Direct |
| Titus B. Ball | ONC | Ordinary Shares | Award | 45.6% | 31,213 | 99,645 | 11 Jun 2026 | Direct | ||
| Lai Wang | ONC | American Depositary Shares | Sale | -100% | $197,318 | $261.00 | -756 | 0 | 11 Jun 2026 | Direct |
| Lai Wang | ONC | Ordinary Shares | Award | 7.45% | 118,625 | 1,710,085 | 11 Jun 2026 | Direct | ||
| Lai Wang | ONC | Share Option (Right to Buy) | Award | 229,775 | 229,775 | 11 Jun 2026 | Direct | |||
| Aaron Rosenberg | ONC | American Depositary Shares | Sale | -100% | $162,637 | $257.74 | -631 | 0 | 11 Jun 2026 | Direct |
| Aaron Rosenberg | ONC | Ordinary Shares | Award | 21.8% | 71,175 | 397,891 | 11 Jun 2026 | Direct | ||
| Aaron Rosenberg | ONC | Share Option (Right to Buy) | Award | 137,865 | 137,865 | 11 Jun 2026 | Direct | |||
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -100% | $163,512 | $261.20 | -626 | 0 | 11 Jun 2026 | Direct |
| Xiaobin Wu | ONC | Ordinary Shares | Award | 9.97% | 118,625 | 1,308,161 | 11 Jun 2026 | Direct | ||
| Xiaobin Wu | ONC | Share Option (Right to Buy) | Award | 229,775 | 229,775 | 11 Jun 2026 | Direct | |||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $110,268 | $257.64 | -428 | 0 | 11 Jun 2026 | Direct |
| Chan Henry Lee | ONC | Ordinary Shares | Award | 15% | 45,071 | 346,554 | 11 Jun 2026 | Direct | ||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Award | 87,308 | 87,308 | 11 Jun 2026 | Direct | |||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $501,355 | $257.24 | -1,949 | 0 | 11 Jun 2026 | Direct |
| John Oyler | ONC | Ordinary Shares | Award | 3.22% | 177,931 | 5,697,649 | 11 Jun 2026 | Direct | ||
| John Oyler | ONC | Share Option (Right to Buy) | Award | 344,669 | 344,669 | 11 Jun 2026 | Direct | |||
| Xiaodong Wang | ONC | Ordinary Shares | Award | 2.18% | 99,892 | 4,682,493 | 11 Jun 2026 | Direct | ||
| Xiaodong Wang | ONC | Share Option (Right to Buy) | Award | 193,492 | 193,492 | 11 Jun 2026 | Direct | |||
| Olivier Brandicourt | ONC | Ordinary Shares | Award | 69.5% | 18,980 | 46,306 | 11 Jun 2026 | Direct | ||
| Anthony C. Hooper | ONC | Ordinary Shares | Award | 29.3% | 18,980 | 83,720 | 11 Jun 2026 | Direct | ||
| Elizabeth Fisher Mooney | ONC | Ordinary Shares | Award | 18,980 | 18,980 | 11 Jun 2026 | Direct |
* marks a reported price that did not pass the local price check.